Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). [electronic resource] by
- Konstan, M W
- VanDevanter, D R
- Rowe, S M
- Wilschanski, M
- Kerem, E
- Sermet-Gaudelus, I
- DiMango, E
- Melotti, P
- McIntosh, J
- De Boeck, K
Producer: 20210913
In:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 19
Availability: No items available.
|